Decreased serum vitamin D level as a prognostic marker in patients with COVID-19
Ruyi Qu, Qiuji Yang, Yingying Bi, Jiajing Cheng, Mengna He, Xin Wei,, Yiqi Yuan, Yuxin Yang, Jinlong Qin

TL;DR
This study found that lower serum vitamin D levels are linked to more severe COVID-19 outcomes in elderly patients, suggesting vitamin D as a potential prognostic marker and therapeutic target.
Contribution
It demonstrates that serum 25(OH)D3 levels independently predict COVID-19 severity and prognosis, highlighting the importance of vitamin D status in disease management.
Findings
Lower vitamin D levels associated with prolonged viral clearance
Vitamin D levels predict COVID-19 severity and prognosis
Supplementation may benefit elderly COVID-19 patients
Abstract
Background: The corona virus disease 2019 (COVID-19) pandemic, which is caused by severe acute respiratory syndrome coronavirus 2, is still localized outbreak and has resulted in a high rate of infection and severe disease in older patients with comorbidities. The vitamin D status of the population has been found to be an important factor that could influence outcome of COVID-19. However, whether vitamin D can lessen the symptoms or severity of COVID-19 still remains controversial. Methods: A total of 719 patients with confirmed COVID-19 were enrolled retrospectively in this study from April 13 to June 6, 2022 at Shanghai Forth People's Hospital. The circulating levels of 25(OH)D3, inflammatory factors, and clinical parameters were assayed. Time to viral RNA clearance (TVRC), classification and prognosis of COVID-19 were used to evaluate the severity of COVID-19 infection. Results: The…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVitamin D Research Studies · Vitamin C and Antioxidants Research · COVID-19 Clinical Research Studies
